Journal of Cardiovascular Disease Research
HFPEF MANAGEMENT AND IMPLICATION OF EMPEROR-PRESERVED IN CLINICAL PRACTICE: INSIGHTS FROM INDIAN CARDIOLOGISTS
Dr. Hemant Narayan Ray, Dr. Pradip Mate, Dr. R. V. Lokesh, Dr. Kamlesh Patel
JCDR. 2023: 2801-2805
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a growing burden to the healthcare system due to the lack of proven therapy to reduce mortality and morbidity. Data from the Trivandrum heart failure registry (THFR) reveals that hospital readmissions significantly associated with mortality in patients with HFpEF having a cumulative one-year mortality rate was 27.3%- and three-years mortality was 40.8%.[1] This survey-based study aimed to evaluate the opinion of cardiology experts on the application of EMPEROR-Preserved trial outcomes in clinical practice
» PDF